Corcept Therapeutics Inc. insider trading

CORTfinancial statementsForm 4 filings on EDGAR509 transactions since Nov 3, 2024

From August 6, 2026 to November 3, 2026, 0 insiders at Corcept Therapeutics Inc. bought $0 of stock in the open market, and 8 sold $42M. Officers and directors accounted for $0 of purchases and $42M of sales. The last reported transaction was an open-market sale by Wilson James N on October 15, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

CORT daily priceSplit-adjusted prices in US dollars

Bought $0Sold $42MAug 6, 2026 – Nov 3, 2026

Nov 3, 2026O $80.92 · H $84.19 · L $80.92 · C $82.29Bought $0 (0)Sold $0 (0)
$77$90$103$116$1292026-08-06: open $111.00, high $111.00, low $107.32, close $107.952026-08-07: open $108.25, high $110.79, low $108.08, close $110.772026-08-10: open $110.84, high $114.63, low $110.05, close $114.232026-08-11: open $114.13, high $114.71, low $111.66, close $111.862026-08-12: open $110.89, high $114.00, low $110.60, close $112.182026-08-13: open $112.53, high $113.00, low $110.23, close $110.512026-08-14: open $110.61, high $114.90, low $110.09, close $114.472026-08-17: open $115.00, high $117.49, low $114.39, close $117.172026-08-18: open $116.60, high $119.95, low $116.60, close $118.102026-08-19: open $119.37, high $121.11, low $118.37, close $119.022026-08-20: open $118.11, high $121.72, low $116.31, close $121.052026-08-21: open $121.48, high $123.44, low $120.56, close $122.252026-08-24: open $120.56, high $124.01, low $119.17, close $123.242026-08-25: open $124.07, high $126.38, low $122.00, close $123.572026-08-26: open $122.57, high $123.64, low $119.74, close $119.802026-08-27: open $119.25, high $121.30, low $116.70, close $116.932026-08-28: open $117.14, high $118.67, low $112.97, close $113.882026-08-31: open $113.64, high $114.53, low $111.23, close $113.352026-09-01: open $113.92, high $115.85, low $111.13, close $113.382026-09-02: open $113.38, high $115.78, low $108.73, close $110.432026-09-03: open $110.38, high $114.61, low $109.43, close $112.802026-09-04: open $110.59, high $112.13, low $109.26, close $111.622026-09-08: open $108.87, high $115.28, low $108.25, close $113.982026-09-09: open $114.20, high $117.50, low $113.77, close $115.702026-09-10: open $114.42, high $116.99, low $113.20, close $114.922026-09-11: open $115.22, high $117.84, low $109.30, close $112.792026-09-14: open $113.38, high $114.52, low $111.10, close $111.802026-09-15: open $111.97, high $112.80, low $109.40, close $110.822026-09-16: open $110.82, high $113.60, low $110.49, close $111.812026-09-17: open $113.18, high $115.09, low $111.07, close $114.862026-09-18: open $116.80, high $117.90, low $108.41, close $110.292026-09-21: open $110.29, high $116.65, low $109.00, close $113.762026-09-22: open $113.96, high $119.00, low $113.09, close $117.512026-09-23: open $117.33, high $118.79, low $112.05, close $112.942026-09-24: open $111.86, high $119.15, low $111.68, close $118.512026-09-25: open $119.00, high $120.44, low $114.51, close $116.102026-09-28: open $116.00, high $117.07, low $114.36, close $115.632026-09-29: open $115.92, high $120.51, low $113.16, close $114.742026-09-30: open $114.80, high $118.07, low $113.98, close $115.232026-10-01: open $114.29, high $115.98, low $111.94, close $114.032026-10-02: open $114.38, high $117.32, low $113.90, close $116.232026-10-05: open $115.59, high $122.81, low $115.50, close $122.032026-10-06: open $122.20, high $122.54, low $115.11, close $119.572026-10-07: open $119.00, high $122.00, low $117.23, close $119.602026-10-08: open $118.56, high $119.16, low $115.80, close $118.542026-10-09: open $118.00, high $122.34, low $117.41, close $121.192026-10-12: open $121.24, high $122.09, low $119.28, close $121.192026-10-13: open $121.83, high $122.81, low $117.42, close $117.802026-10-14: open $117.94, high $122.21, low $115.95, close $116.232026-10-15: open $116.31, high $117.48, low $113.02, close $113.372026-10-16: open $113.17, high $113.64, low $107.79, close $110.162026-10-19: open $111.70, high $113.09, low $110.50, close $112.102026-10-20: open $112.60, high $117.14, low $111.96, close $116.452026-10-21: open $116.45, high $118.42, low $116.10, close $116.282026-10-22: open $115.16, high $115.73, low $107.44, close $107.502026-10-23: open $106.05, high $106.09, low $84.13, close $85.862026-10-26: open $86.10, high $91.78, low $85.86, close $87.132026-10-27: open $85.31, high $87.97, low $84.91, close $87.592026-10-28: open $86.43, high $88.59, low $86.00, close $86.282026-10-29: open $86.07, high $88.01, low $85.21, close $85.952026-10-30: open $85.00, high $85.31, low $80.28, close $81.122026-11-02: open $80.93, high $82.23, low $79.40, close $80.462026-11-03: open $80.92, high $84.19, low $80.92, close $82.29Insider purchases / sales · USD$20M$0−$20M2026-08-10: 0 purchases ($0), 3 sales ($2M)2026-08-14: 0 purchases ($0), 4 sales ($2M)2026-08-17: 0 purchases ($0), 1 sales ($1M)2026-08-18: 0 purchases ($0), 4 sales ($12M)2026-08-25: 0 purchases ($0), 2 sales ($4M)2026-08-26: 0 purchases ($0), 1 sales ($3M)2026-09-01: 0 purchases ($0), 3 sales ($3M)2026-09-02: 0 purchases ($0), 7 sales ($6M)2026-09-14: 0 purchases ($0), 2 sales ($1M)2026-09-15: 0 purchases ($0), 3 sales ($1M)2026-09-16: 0 purchases ($0), 1 sales ($30K)2026-10-01: 0 purchases ($0), 2 sales ($141K)2026-10-02: 0 purchases ($0), 7 sales ($5M)2026-10-15: 0 purchases ($0), 3 sales ($1M)Aug 6Aug 28Sep 21Oct 13Nov 3

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 3, 2026. Insider data through Nov 3, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

509 transactions from November 3, 2024 to November 3, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect6,654$114.48$762K1MOct 16, 2026
Oct 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect3,046$115.39$351K1MOct 16, 2026
Oct 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect300$116.30$35K1MOct 16, 2026
Oct 2, 2026Vieira Roberto WandenkolkPresident, Oncologyoption exercise8,333$21.63$180K12,279Oct 5, 2026
Oct 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-11,100$114.52$126K11,179Oct 5, 2026
Oct 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-12,086$115.73$241K9,093Oct 5, 2026
Oct 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-15,147$116.58$600K3,946Oct 5, 2026
Oct 2, 2026Lyon Joseph DouglasSee Remarksoption exercise3,357$13.56$46K9,040Oct 5, 2026
Oct 2, 2026Lyon Joseph DouglasSee Remarksoption exercise5,833$19.26$112K14,873Oct 5, 2026
Oct 2, 2026Lyon Joseph DouglasSee Remarksopen-market sale10b5-14,446$115.70$514K10,427Oct 5, 2026
Oct 2, 2026Lyon Joseph DouglasSee Remarksopen-market sale10b5-14,744$116.54$553K5,683Oct 5, 2026
Oct 2, 2026Maduck SeanSee Remarksoption exercise24,587$8.27$203K34,525Oct 5, 2026
Oct 2, 2026Maduck SeanSee Remarksopen-market sale10b5-115,843$116.12$2M18,682Oct 5, 2026
Oct 2, 2026Maduck SeanSee Remarksopen-market sale10b5-18,744$116.55$1M9,938Oct 5, 2026
Oct 1, 2026Lyon Joseph DouglasSee Remarksoption exercise810$13.56$11K6,493Oct 5, 2026
Oct 1, 2026Lyon Joseph DouglasSee Remarksopen-market sale10b5-1810$115.40$93K5,683Oct 5, 2026
Oct 1, 2026Maduck SeanSee Remarksoption exercise413$8.27$3K10,351Oct 5, 2026
Oct 1, 2026Maduck SeanSee Remarksopen-market sale10b5-1413$115.54$48K9,938Oct 5, 2026
Sep 24, 2026Robb Gary CharlesChief Business Officergift17,100$0.00—14,056Sep 28, 2026
Sep 24, 2026Robb Gary CharlesChief Business Officergiftindirect5,000$0.00—20,571Sep 28, 2026
Sep 17, 2026Robb Gary CharlesChief Business Officeroption exercise17,493$8.27$145K31,156Sep 18, 2026
Sep 16, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-1296$100.82$30K3,946Sep 18, 2026
Sep 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect6,800$110.27$750K1MSep 16, 2026
Sep 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect400$110.84$44K1MSep 16, 2026
Sep 15, 2026Wilson James NDirectoropen-market sale10b5-1indirect2,800$111.70$313K1MSep 16, 2026
Sep 14, 2026Lyon Joseph DouglasSee Remarksoption exercise2,596$11.35$29K8,279Sep 16, 2026
Sep 14, 2026Lyon Joseph DouglasSee Remarksoption exercise7,404$13.56$100K15,683Sep 16, 2026
Sep 14, 2026Lyon Joseph DouglasSee Remarksopen-market sale10b5-17,812$113.32$885K7,871Sep 16, 2026
Sep 14, 2026Lyon Joseph DouglasSee Remarksopen-market sale10b5-12,188$114.12$250K5,683Sep 16, 2026
Sep 2, 2026Maduck SeanSee Remarkstax withholding117$113.38$13K9,938Sep 3, 2026
Sep 2, 2026Mokari AtabakChief Financial Officertax withholding102$113.38$12K16,304Sep 3, 2026
Sep 2, 2026Robb Gary CharlesChief Business Officertax withholding91$113.38$10K13,663Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologytax withholding102$113.38$12K4,242Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyoption exercise58,333$21.63$1M62,575Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-123,600$109.35$3M38,975Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-123,770$110.70$3M15,205Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-11,537$111.37$171K13,668Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-1974$112.40$109K12,694Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-11,606$113.72$183K11,088Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-15,621$114.58$644K5,467Sep 3, 2026
Sep 2, 2026Vieira Roberto WandenkolkPresident, Oncologyopen-market sale10b5-11,225$115.44$141K4,242Sep 3, 2026
Sep 2, 2026Lyon Joseph DouglasSee Remarkstax withholding72$113.38$8K5,683Sep 3, 2026
Sep 1, 2026Guyer WilliamChief Development Officeraward164$113.38$19K4,149Sep 3, 2026
Sep 1, 2026Guyer WilliamChief Development Officeraward164$0.00—4,313Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksoption exercise25,000$8.27$207K34,755Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksopen-market sale10b5-111,730$113.94$1M23,025Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksopen-market sale10b5-110,989$114.71$1M12,036Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksopen-market sale10b5-12,281$115.61$264K9,755Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksaward150$113.38$17K9,905Sep 3, 2026
Sep 1, 2026Maduck SeanSee Remarksaward150$0.00—10,055Sep 3, 2026

Who the insiders are

Everyone who reported a transaction since November 3, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Maduck SeanSee RemarksOct 2, 2026option exercise34,525—$24M (20)20 of 20
Mokari AtabakChief Financial OfficerSep 2, 2026tax withholding16,304—$19M (22)22 of 22
Mahoney David LDirectorAug 18, 2026open-market sale30,000—$14M (5)4 of 5
Guyer WilliamChief Development OfficerSep 1, 2026award4,149—$13M (19)17 of 19
Belanoff Joseph KChief Executive Officer, DirectorJun 1, 2026open-market sale243,154—$10M (8)8 of 8
Vieira Roberto WandenkolkPresident, OncologyOct 2, 2026option exercise12,279—$7M (11)11 of 11
Wilson James NDirectorOct 15, 2026open-market sale0—$5M (15)15 of 15
Lyon Joseph DouglasSee RemarksOct 2, 2026option exercise9,040—$4M (9)7 of 9
Baker G Leonard JRDirectorMar 17, 2026open-market buy1M$3M (2)——
Park KimberlyDirectorAug 26, 2026option exercise30,000—$3M (1)0 of 1
Robb Gary CharlesChief Business OfficerSep 24, 2026gift14,056—$1M (1)0 of 1
Swisher Daniel N JRDirectorOct 10, 2025open-market sale0———
Hunt HazelChief Scientific OfficerFeb 9, 2026option exercise333,405———
Cannon GillianDirectorSep 10, 2025gift0———

Questions

Are Corcept Therapeutics Inc. insiders buying or selling?

Over the twelve months to November 3, 2026, 10 insiders at Corcept Therapeutics Inc. sold $102M of stock in the open market, all by officers and directors, and 1 insider bought $3M, all by officers and directors. Net, insiders sold $98M. Only open-market purchases and sales are counted.

Who sold the most Corcept Therapeutics Inc. stock in the last year?

Maduck Sean (See Remarks) sold $24M in 20 open-market sales over the twelve months to November 3, 2026.

Do Corcept Therapeutics Inc. executives sell under 10b5-1 plans?

104 of the 111 open-market sales in the last twelve months (94%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on Corcept Therapeutics Inc.

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.